Skip to content
Research/Exosome Therapies/Exosome Joint Injection

Exosome Joint Injection

Exosome therapy for joint and tendon regeneration support. Therapy administered via intra-articular injection.

Intelligence Profile

Research Papers

Current research on exosome joint injections is largely in the preclinical stage, with studies primarily focusing on animal models and tissue engineering applications rather than direct clinical use.

Preclinical Studies

Several 2026 studies have explored exosome delivery systems for joint conditions. One study examined a thermosensitive hydrogel system delivering wogonin-treated mesenchymal stromal cell (MSC)-derived exosomes for osteoarthritis treatment. Another investigated ROS-responsive hydrogels delivering CircSERPINE2-loaded exosomes for cartilage repair, while a third studied microfluidic hyaluronic acid microspheres incorporating exosomes for antioxidant and anti-inflammatory effects in osteoarthritis.

A promising animal study published in the Journal of Orthopaedic Research (2026) tested intra-articular injection of purified exosome products combined with hyaluronan in a turkey model of osteoarthritis, showing attenuation of disease progression. However, the study size and specific methodology details are not provided in the available abstracts.

Research has also examined the molecular mechanisms, with one study identifying that bone marrow MSC-derived exosomal miR-27a-3p may help osteoarthritis through dual effects on cartilage protection and immune regulation via TXNIP/NLRP3 signaling pathways.

Clinical Trials

Several early-phase clinical trials are underway or recently completed, though detailed results are not yet available:

  • NCT05060107 (ExoOA-1): A Phase 1 trial examining intra-articular injection of MSC-derived exosomes in knee osteoarthritis
  • NCT06431152: An early Phase 1 study of umbilical cord MSC exosomes for knee osteoarthritis
  • NCT06466850: A trial investigating MSC-derived exosomes in osteoarthritis patients (currently recruiting)
  • NCT05261360: A Phase 2 trial examining exosomes for degenerative meniscal injury

Important Limitations

The current evidence base is quite limited. Most studies are preclinical animal or laboratory research, and the human clinical trials listed do not yet have published results or detailed methodology available. Study designs, sample sizes, and outcome measures for the clinical trials are not specified in the available data.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare provider for personalized treatment recommendations.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.